WaveLight EX500 Excimer Laser

Alcon introduced its latest innovation in LASIK surgery technology, the WaveLight® EX500 excimer laser, during the 2012 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting in Chicago, Illinois. This is the first refractive surgery innovation that Alcon has unveiled since its merger with Novartis in April 2011. 'When Novartis acquired Alcon in 2011, we committed that our combined strength would provide additional benefits to our customers and their patients, delivering better services and bringing innovation to the market faster,' said Stuart Raetzman, area president, Alcon US. 'The new WaveLight EX500 excimer laser is the first refractive surgery innovation to be offered by the new Alcon. It provides enhanced customisation for our customers – saving time and delivering excellent refractive outcomes.'
www.alconsurgical.com
Latest Articles
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.
AI Analysis and the Cornea
A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.
Cooking a Feast for the Eyes
A cookbook to promote ocular health through thoughtful and traditional cuisine.
Need to Know: Spherical Aberration
Part three of this series examines spherical aberration and its influence on higher-order aberrations.
Generating AI’s Potential
How generative AI impacts medicine, society, and the environment.